N
KDNY

Natixis’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Natixis’s Portfolio KDNY Stock Details KDNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,352
Closed -$51.9K – 1150
2023
Q2 		$51.9K Buy
+1,352
New +$51.9K ﹤0.01% 828